tiprankstipranks
Advertisement
Advertisement
enVVeno Medical Wins FDA IDE for TAVVE Trial
PremiumCompany AnnouncementsenVVeno Medical Wins FDA IDE for TAVVE Trial
2M ago
enVVeno Medical reports FY25 EPS ($33.06) vs. ($44.53) last year
Premium
The Fly
enVVeno Medical reports FY25 EPS ($33.06) vs. ($44.53) last year
3M ago
enVVeno Medical expects cash burn rate of $4M-$5M per quarter in 2026
Premium
The Fly
enVVeno Medical expects cash burn rate of $4M-$5M per quarter in 2026
3M ago
Upcoming Stock Splits This Week (January 20 to January 23) – Stay Invested
PremiumMarket NewsUpcoming Stock Splits This Week (January 20 to January 23) – Stay Invested
6M ago
enVVeno Medical trading halted, news pending
Premium
The Fly
enVVeno Medical trading halted, news pending
6M ago
enVVeno Medical board approves 1-for-35 reverse stock split
Premium
The Fly
enVVeno Medical board approves 1-for-35 reverse stock split
6M ago
enVVeno Medical receives unfavorable FDA decision for VenoValve
PremiumThe FlyenVVeno Medical receives unfavorable FDA decision for VenoValve
8M ago
enVVeno Medical trading halted, news pending
Premium
The Fly
enVVeno Medical trading halted, news pending
8M ago
enVVeno Medical reports Q3 EPS (23c) vs. (35c) last year
Premium
The Fly
enVVeno Medical reports Q3 EPS (23c) vs. (35c) last year
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100